What Researchers Did
Researchers performed a meta-analysis of clinical cases to evaluate the effectiveness of hyperbaric oxygen (HBO) therapy for life-threatening soft-tissue infections.
What They Found
They found that hyperbaric oxygen therapy, when combined with prompt recognition, antibiotic therapy, and aggressive surgical debridement, significantly reduces the high mortality associated with necrotizing soft-tissue infections. HBO augments tissue oxygen, enhancing bacterial killing, increasing capillary formation, and improving antibiotic efficacy and wound healing.
What This Means for Canadian Patients
Canadian patients suffering from severe, rapidly spreading soft-tissue infections may benefit from hyperbaric oxygen therapy as an adjunctive treatment. This therapy, alongside standard care, could improve outcomes and reduce the risk of mortality.
Canadian Relevance
There is no specific Canadian connection mentioned in this study.
Study Limitations
A significant limitation is the absence of randomized controlled trials specifically evaluating hyperbaric oxygen therapy for these infections.